Search

Objective: To conduct a long‐term retrospective evaluation of the safety and effectiveness of sialographic balloon dilatation in Stensen's duct stenosis (SDS). Study Design: Retrospective cohort. Setting: Single‐institution academic tertiary referral center. Methods: All SDS balloon dilatations (SSBDs) performed from 2011 to 2017 were monitored. Pain relief was evaluated by a numeric rating scale at 3‐year follow‐up at least. Long‐term glandular swelling frequency patterns, quality of life (QoL), and drug consumption were retrospectively assessed. Procedure‐related complications were recorded. Results: Twenty‐one SSBD procedures were recorded (mean ± SD age, 55 ± 12 years), all performed under local anesthesia. SSBD led to complete dilatation in 7 patients (33%), residual stenosis in 8 (38%), and no dilatation (failure) in 6 (29%). Retrospective analysis of clinical outcomes was possible for 17 patients, 71% of whom presented with long‐term pain relief, at a mean relief of 3.2 points on the numeric rating scale (P <.001). Long after SSBD, patients presented with a mean decrease of 15.4 glandular swellings per month (P <.001). Medical consumption was reduced to 18% of patients taking some drugs because of SDS after SSBD vs 71% before. SSBD showed an impact on QoL in >80% of patients, with mean improvements of 26% and 25% in the percentage point reduction of physical and mental QoL, respectively (P <.001). No complications were noted except temporary discomfort due to the procedure. Conclusion: Despite the advent of sialendoscopy‐guided techniques, SSBD should be considered for SDS treatment, as it is a safe procedure and provides sustained pain relief. [ABSTRACT FROM AUTHOR]

Objective: The aim of this study was to evaluate the recurrence rate of lithiasis following minimally invasive surgery to identify risk factors and mechanisms for recurrence of salivary gland lithiasis. Study Design: Retrospective case series. Methods: A retrospective study was conducted including all patients treated for salivary gland lithiasis by minimally invasive surgery, such as sialendoscopy, intracorporeal lithotripsy, extracorporeal lithotripsy, transoral approach, and combined approach in our Department. We analyzed the recurrence rate of salivary lithiasis, their topography and timeline. Result: Three hundred four patients were included in this study, the mean age was 49 years (range 12–90 years), and the mean duration of follow‐up was 19.8 months (range 0–66 months). Fifteen patients (5%) presented secondary lithiasis. In all but one case, recurrences involved the same gland as primary lithiasis, and most frequently the submandibular gland. Recurrences occurred from 3 to 46 months postoperatively. Fourteen patients, who presented recurrence, had been initially treated by transoral approach. Recurrent lithiasis were treated by transoral approach or submandibulectomy. Conclusion: Salivary gland lithiasis recurrence was rare after minimally invasive salivary gland surgery. This study reinforced the concept that salivary gland lithiasis should be considered as a duct pathology. Level of Evidence: 4 Laryngoscope, 131:794–799, 2021 [ABSTRACT FROM AUTHOR]

Background: Although many studies focus on short‐term side effects of radioiodine therapy, almost none studied long‐term side effects. We assessed radioiodine long‐term salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma and compared it to short‐term morbidity within the same population. Methods: A standardized self‐administrated questionnaire was submitted in 2019 by patients treated with radioiodine between January 2011 and December 2012. These patients had already answered the same questionnaire 6 years before. Results: Our study showed a significant reduction for salivary side effects: discomfort in submandibular or parotid area, swelling, pain, a bad or salty taste in the mouth, allowing to get back to a "normal" diet. Conclusions: Our study suggests that a significant rate of patients will recover from I131 therapy salivary side effects. As almost 30% of these remissions happened during our late stage follow‐up, we highlight the necessity of a long‐term follow‐up in these patients. [ABSTRACT FROM AUTHOR]